Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1978 1
1985 1
1988 1
1990 2
1991 2
1994 1
1996 1
1997 1
1999 1
2000 1
2005 1
2010 2
2011 1
2012 1
2016 1
2017 1
2018 1
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Results by year
Filters applied: . Clear all
Page 1
Factors targeting MED12 to drive tumorigenesis?
Bullerdiek J, Rommel B. Bullerdiek J, et al. Among authors: rommel b. F1000Res. 2018 Mar 22;7:359. doi: 10.12688/f1000research.14227.2. eCollection 2018. F1000Res. 2018. PMID: 30647905 Free PMC article.
Comment re: HMGA2 is a negative regulator of DNA-PK pathway.
Bullerdiek J, Rommel B. Bullerdiek J, et al. Among authors: rommel b. Cancer Res. 2010 Feb 15;70(4):1742; author reply 1742. doi: 10.1158/0008-5472.CAN-09-3081. Epub 2010 Feb 9. Cancer Res. 2010. PMID: 20145117 Free article. No abstract available.
Interphase fluorescence in situ hybridization analysis detects a much higher rate of thyroid tumors with clonal cytogenetic deviations of the main cytogenetic subgroups than conventional cytogenetics.
Drieschner N, Rippe V, Laabs A, Dittberner L, Nimzyk R, Junker K, Rommel B, Kiefer Y, Belge G, Bullerdiek J, Sendt W. Drieschner N, et al. Among authors: rommel b. Cancer Genet. 2011 Jul;204(7):366-74. doi: 10.1016/j.cancergen.2011.03.008. Cancer Genet. 2011. PMID: 21872823
23 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page